Blood Cancer Talks

This podcast on the management of blood cancers and hematology is hosted by Raj Chakraborty, MD; Ashwin Kishtagari, MD; and Edward Cliff, MD.

Articles by Blood Cancer Talks

Blood Cancer TalksBlood Cancer Talks | February 27, 2024
Dr. Dispenzieri, of the Mayo Clinic, joins the "Blood Cancer Talks" hosts to discuss how to treat and manage AL amyloidosis.
Listen Now
Blood Cancer TalksAcute Myeloid Leukemia | February 13, 2024
Dr. Patel and the hosts discuss the TRANSFORM-1 study, MANIFEST-2, AUGMENT-101, and more.
Blood Cancer TalksBlood Cancer Talks | January 31, 2024
Dr. Eyre and the hosts discuss lymphoma abstracts from ASH 2023, including the FLAIR trial and the SYMPATICO trial.
Blood Cancer TalksBlood Cancer Talks | January 24, 2024
Shernan Holtan, MD, and the hosts discuss recent data on graft versus host disease prophylaxis.
Blood Cancer TalksBlood Cancer Talks | January 10, 2024
Dr. Derman and the hosts discuss myeloma abstracts from ASH 2023, including the PERSEUS trial and the KarMMa-3 trial.
Blood Cancer TalksBlood Cancer Talks | December 5, 2023
Dr. Dickinson joins "Blood Cancer Talks" hosts to discuss phase I and II trials on DLBCL, follicular lymphoma, and more.
Blood Cancer TalksBlood Cancer Talks | December 6, 2023
Alexander Perl, MD, joins the hosts to discuss the management of newly diagnosed and relapsed FLT3-positive AML.
Blood Cancer TalksBlood Cancer Talks | November 22, 2023
The episode also discusses Dr. Raza's book, "The First Cell," which recounts stories of her patients with terminal cancer.
Blood Cancer TalksBlood Cancer Talks | October 19, 2023
Kate Cwynarski, MBBS, PhD, of the University of College London, discusses the management of CNS lymphomas.
Blood Cancer TalksBlood Cancer Talks | October 20, 2023
This episode of "Blood Cancer Talks" discusses the biology and management of multiple myeloma and the role of venetoclax.
Blood Cancer TalksBlood Cancer Talks | October 18, 2023
The episode also highlights the S1211 study, which is the first randomized controlled trial with high-risk enrichment in MM.
Blood Cancer TalksBlood Cancer Talks | August 31, 2023
Dr. Horwitz and the hosts focus on the three most common types of PTCL and the latest research.
Blood Cancer TalksBlood Cancer Talks | August 30, 2023
Uma Borate, MBBS, joins the hosts to discuss CCUS and the latest data.
Blood Cancer TalksBlood Cancer Talks | July 19, 2023
Dr. Bartlett and the hosts explore the history of first-line treatments for patients with Hodgkin lymphoma.
Blood Cancer TalksBlood Cancer Talks | July 19, 2023
Dr. Jain discusses how he addresses the acute toxicities that can arise after CAR T-cell therapy.
Blood Cancer TalksBlood Cancer Talks | June 29, 2023
The hosts discuss the latest data on CAR-T from the summer conference season.
Blood Cancer TalksMyeloproliferative Neoplasms | August 1, 2023
Dr. Sekeres also speaks about his time on the FDA ODAC and his latest book, titled "Drugs and the FDA."
Blood Cancer TalksBlood Cancer Talks | August 15, 2023
Dr. Chari and the hosts also discuss a phase I trial of fixed-duration cevostamab, as well as a phase I trial of ABBV-383.
Blood Cancer TalksMantle Cell Lymphoma | August 1, 2023
Dr. Dreyling discusses the management of newly diagnosed MCL and considerations in light of the TRIANGLE trial.
Blood Cancer TalksBlood Cancer Talks | August 1, 2023
The episode was inspired by an article titled “The Underrepresented Majority" by Andrés Gómez-De León, MD.